Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,957 | -88,612 | -76,842 | -55,884 | -28,530 |
| Depreciation Amortization | 106 | 555 | 442 | 286 | 138 |
| Accounts receivable | N/A | 1,024 | N/A | 932 | N/A |
| Accounts payable and accrued liabilities | -2,949 | -4,078 | -502 | -3,385 | 1,848 |
| Other Working Capital | -2,655 | 10,159 | 14,059 | 5,990 | 9,552 |
| Other Operating Activity | 4,852 | 18,681 | 17,859 | 17,968 | 4,683 |
| Operating Cash Flow | $-15,603 | $-62,271 | $-44,984 | $-34,093 | $-12,309 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -55 | -55 | -52 | -4 |
| Purchase Of Investment | -64,427 | -166,413 | N/A | -72,449 | -70,060 |
| Other Investing Activity | 74,427 | 118,476 | 5,401 | 26,558 | 25,683 |
| Investing Cash Flow | $10,000 | $-47,992 | $5,346 | $-45,943 | $-44,381 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 15 | 15 | 15 | 14 |
| Financing Cash Flow | $N/A | $15 | $15 | $15 | $14 |
| Exchange Rate Effect | -17 | 195 | 324 | 430 | 232 |
| Beginning Cash Position | 11,277 | 121,330 | 121,330 | 121,330 | 121,330 |
| End Cash Position | 5,657 | 11,277 | 82,031 | 41,739 | 64,886 |
| Net Cash Flow | $-5,620 | $-110,053 | $-39,299 | $-79,591 | $-56,444 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,603 | -62,271 | -44,984 | -34,093 | -12,309 |
| Capital Expenditure | N/A | -55 | -55 | -52 | -4 |
| Free Cash Flow | -15,603 | -62,326 | -45,039 | -34,145 | -12,313 |